Expertise, Technology, and Infrastructure for Your Tuberculosis Testing Needs

TB Testing CapabilitiesThe theme for World Tuberculosis (TB) Day 2018 is “Wanted: Leaders for a TB-free world”. Q2 Solutions’ industry-leading scientists have over 35 years experience in infectious disease and immunology assay development and clinical trial testing.

Having a vaccine center of excellence in Pretoria, South Africa with dedicated TB testing capabilities, we proudly aim to make a contribution to a globally united effort to end TB.

Download our new infographic to learn more about how our specialized TB testing capabilities, expertise, and infrastructure can help advance your study.

Related Services: Related Blogs:
Q2 Solutions Anti-infective and Vaccine Development Services

Delivery Excellence for Anti-infective and Vaccine Development

Supply chain and quality management systems to ensure sample integrity for high-quality data delivery

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges

Combating Emerging and Re-Emerging Infectious Diseases in Clinical Trials by Harnessing Innovative Technologies

Read More